...
首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach
【24h】

Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach

机译:通过简单的组装方法制备具有可控药物加载和释放的磁性纳米颗粒

获取原文
获取原文并翻译 | 示例

摘要

Nanoparticle-based cancer therapeutics promises to improve drug delivery safety and efficacy. However, fabrication of consistent theranostic nanoparticles with high and controllable drug loading remains a challenge, primarily due to the cumbersome, multi-step synthesis processes conventionally applied. Here, we present a simple and highly controllable method for assembly of theranostic nanoparticles, which may greatly reduce batch-to-batch variation. The major components of this nanoparticle system include a superparamagnetic iron oxide nanoparticle (SPION), a biodegradable and pH-sensitive poly (beta-amino ester) (PBAE) copolymer, a chemotherapeutic agent doxorubicin (DOX). Here the polymer pre-loaded with drug is directly assembled to the surface of SPIONs forming a drug loaded nanoparticle (NP-DOX). NP-DOX demonstrated a high drug loading efficiency of 679 μg DOX per mg iron, sustained stability in cell culture media up to 7 days, and a strong r_2 relaxivity of 146 mM~(- 1)?s~(- 1) for magnetic resonance imaging (MRI). The drug release analysis of NP-DOX showed fast DOX release at pH 5.5 and 6.4 (as in endosomal environment) and slow release at pH 7.4 (physiological condition), demonstrating pH-sensitive drug release kinetics. In vitro evaluation of NP-DOX efficacy using drug-resistant C6 glioma cells showed a 300% increase in cellular internalization at 24 h post-treatment and 65% reduction of IC50 at 72 h post-treatment when compared to free DOX. These nanoparticles could serve as a foundation for building smart theranostic formulations for sensitive detection through MRI and effective treatment of cancer by controlled drug release.
机译:基于纳米粒子的癌症治疗剂有望改善药物递送的安全性和功效。然而,主要由于常规应用的繁琐的多步合成方法,制造具有高且可控制的药物载量的一致的治疗药物纳米颗粒仍然是一个挑战。在这里,我们提出了一个简单且高度可控制的方法,用于组装纳米颗粒,可以大大减少批次间的差异。该纳米粒子系统的主要成分包括超顺磁性氧化铁纳米粒子(SPION),可生物降解且对pH敏感的聚(β-氨基酯)(PBAE)共聚物,化学治疗剂阿霉素(DOX)。在这里,预先装载有药物的聚合物直接组装到SPIONs的表面上,从而形成了装载药物的纳米颗粒(NP-DOX)。 NP-DOX具有679μgDOX / mg铁的高载药量,在细胞培养基中可保持长达7天的持续稳定性,并且对磁的强r_2弛豫性为146 mM〜(-1)?s〜(-1)共振成像(MRI)。 NP-DOX的药物释放分析表明,在pH 5.5和6.4下(如在内体环境中)DOX快速释放,在pH 7.4(生理条件)下缓慢释放,证明了pH敏感的药物释放动力学。与游离DOX相比,使用抗药性C6胶质瘤细胞进行的NP-DOX功效的体外评估显示,在治疗后24小时内,细胞内在化程度提高了300%,在治疗72小时后IC50降低了65%。这些纳米颗粒可作为构建智能化治疗药物制剂的基础,以通过MRI灵敏检测并通过控制药物释放有效治疗癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号